首页> 美国卫生研究院文献>Springer Open Choice >Paclitaxel and cisplatin chemotherapy for ovarian cancer during pregnancy: case report and review of the literature
【2h】

Paclitaxel and cisplatin chemotherapy for ovarian cancer during pregnancy: case report and review of the literature

机译:紫杉醇联合顺铂化疗治疗妊娠期卵巢癌:病例报告及文献复习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The safety of chemotherapy during pregnancy is debatable. We present a case of advanced ovarian cancer, diagnosed at week 28 of gestational age, treated with 2 cycles of paclitaxel/cisplatin (TC) chemotherapy during pregnancy, with no serious toxicity. At week 34, the patient underwent a caesarean section and delivered a healthy girl. Four additional cycles of TC were administered. Three months after completing chemotherapy, the patient developed abdominal progression and subsequently a huge metastatic cystic mass in the brain. Despite subsequent therapies, the patient died of progressive disease 35 months after the diagnosis. The infant had normal growth and development by 73 months of her age. This is another reported case of ovarian cancer diagnosed during the second trimester of the pregnancy treated with TC chemotherapy without apparent teratogenic effect.
机译:怀孕期间化疗的安全性尚有争议。我们提出了一例晚期卵巢癌,诊断为胎龄28周,在怀孕期间接受2周期紫杉醇/顺铂(TC)化疗,无严重毒性。在第34周时,患者接受了剖腹产并分娩出健康的女孩。进行了四个额外的TC周期。完成化疗三个月后,患者出现腹部进展,随后脑部出现巨大的转移性囊性肿块。尽管进行了后续治疗,但患者在诊断后35个月死于进行性疾病。婴儿在其73个月大时已正常生长发育。这是另一例报道的经TC化疗治疗的妊娠中期妊娠卵巢癌,无明显致畸作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号